The Importance of IRT in the Decentralized Clinical Trial Landscape

The Importance of IRT in the Decentralized Clinical Trial Landscape
December 15, 2022 YPrime

Patient-centric trials such as decentralized clinical trials (DCTs) or hybrid clinical trials can create complex challenges for drug management and distribution.

Interactive Response Technology (IRT) plays an increasingly significant role in delivering an efficient and streamlined experience for patients, sites, and sponsors. Understanding how this technology can be used more effectively to deliver a better experience while minimizing risks to clinical trials will be one key to the successful adoption of decentralized and hybrid clinical trials.

Watch the webinar to learn more.

WEBINAR

The Importance of IRT in the Decentralized Clinical Trial Landscape

Jon Paras

RELATED CONTENT

Getting Better Together Initiative eCOA Lexicon

Getting Better Together Initiative eCOA Lexicon

How to Get the Most Out of Your eCOA Data

How to Get the Most Out of Your eCOA Data

Is BYOD right for your  eCOA Clinical Trial?

Is BYOD right for your eCOA Clinical Trial?

LATEST CONTENT

Effective Use of IRT in Decentralized and Hybrid Clinical Trials

Effective Use of IRT in Decentralized and Hybrid Clinical Trials

Improving DCT Technologies for Efficient and Personalized Delivery

Improving DCT Technologies for Efficient and Personalized Delivery

The Importance of IRT in the Decentralized Clinical Trial Landscape

The Importance of IRT in the Decentralized Clinical Trial Landscape